## Abstract The aim of this study was to describe a competition between cytarabine (araC) and aspirin (ASA) in binding with bovine serum albumin (BSA). High‐affinity binding sites for both drugs were determined using a spectrofluorimetric method. Cytarabine as well as aspirin binds in the IIA hydro
Competition of drugs to serum albumin in combination therapy
✍ Scribed by Anna Sułkowska; Barbara Bojko; Joanna Równicka; Wiesław Sułkowski
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2004
- Tongue
- English
- Weight
- 264 KB
- Volume
- 74
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The mechanism of cooperative binding of both cytarabine and fluorouracil, used in combination therapy, to the transporting protein [bovine serum albumin (BSA)] has been investigated. Present study shows a strategy of estimating the kind of competition between these drugs with the use of uv and NMR spectroscopy. Two mechanisms of the competition to the transporting protein are proposed. For the quantitative investigations the effect of the protein on both the line width and chemical shifts of the NMR signals of the 5‐fluorouracil and cytarabine was analyzed. The π–π interaction between the pyrimidine ring of the drugs and the aromatic residues of the protein has been postulated. The binding site for both 5‐fluorouracil and cytarabine on BSA was found to be situated in the hydrophobic IIA subdomain. The competition of these two drugs and the removal of 5‐fluorouracil by cytarabine from the common binding site in serum albumin tertiary structure are observed. © 2004 Wiley Periodicals, Inc. Biopolymers, 2004
📜 SIMILAR VOLUMES
The binding properties of hypoglycaemic drugs to glycosylated human serum albumin (G-HSA) were investigated using a ¯uorescence quenching method. Displacement patterns between tolbutamide and Sudlow's-site-speci®c drugs to G-HSA were also investigated. The order of the binding anities of these drug
A technique based on a human serum albumin (HSA) stationary phase high-pressure liquid chromatography (HPLC) has been successfully used for the past few years to characterize the interactions between HSA and new substrates. Immobilized HSA conserves the binding properties of the protein in solution,